Skip to main content
S 1391 116th Congress Senate Health Business records Civil actions and liability Congressional oversight Consumer affairs Corporate finance and management Government information and archives Government studies and investigations Health care costs and insurance Inflation and prices Manufacturing Marketing and advertising Medical research Prescription drugs Research and development

Fair Accountability and Innovative Research Drug Pricing Act of 2019

Introduced: May 9, 2019 Introduced by: Baldwin, Tammy Democratic · Wisconsin See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 9, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
May 9, 2019
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Fair Accountability and Innovative Research Drug Pricing Act of 2019

This bill requires manufacturers to report about certain price increases for prescription drugs and biological products with a wholesale cost of at least $100 per month. Such reports must include, among other information (1) the percentage price increase, (2) a justification for such increase, (3) the price history of the drug, (4) the total cost to develop the drug, and (5) the total revenue and net profit generated from the drug.

What's happening now May 9, 2019

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 2
  • S 1895 Related bill Lower Health Care Costs Act
  • HR 2296 Related bill More Efficient Tools to Realize Information for Consumers Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 5
All 5 Democratic 1 Republican 3 Independent 1
R
Cramer, Kevin
North Dakota · Sep 9, 2019
 R
Hoeven, John
North Dakota · Aug 1, 2019
 I
King, Angus S., Jr.
Maine · Aug 1, 2019
 R
Murkowski, Lisa
Alaska · May 9, 2019
 D
Smith, Tina
Minnesota · May 9, 2019
Cite this page click to expand
APA
U.S. Congress. (2026). S. 1391: Fair Accountability and Innovative Research Drug Pricing Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-S-1391/
MLA
"S. 1391: Fair Accountability and Innovative Research Drug Pricing Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-1391/.
Bluebook (legal)
S. 1391, 116th Cong. (2026), https://openamerica.io/bill/116-S-1391/.
Markdown link
[S. 1391: Fair Accountability and Innovative Research Drug Pricing Act of 2019](https://openamerica.io/bill/116-S-1391/)
Report a problem